Found: 22
Select item for more details and to access through your institution.
FOXP1 is a regulator of quiescence in healthy human CD4<sup>+</sup> T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.
- Published in:
- European Journal of Immunology, 2017, v. 47, n. 1, p. 168, doi. 10.1002/eji.201646373
- By:
- Publication type:
- Article
Hypereosinophilic syndromes.
- Published in:
- Orphanet Journal of Rare Diseases, 2007, v. 2, p. 37, doi. 10.1186/1750-1172-2-37
- By:
- Publication type:
- Article
What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?
- Published in:
- Seminars in Immunopathology, 2021, v. 43, n. 3, p. 439, doi. 10.1007/s00281-021-00857-w
- By:
- Publication type:
- Article
Predictive Markers for Development of Severe Organ Involvement in Patients with Systemic Sclerosis.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1051, n. 1, p. 455, doi. 10.1196/annals.1361.087
- By:
- Publication type:
- Article
Real-Life Study of Mepolizumab in Idiopathic Chronic Eosinophilic Pneumonia.
- Published in:
- Lung, 2020, v. 198, n. 2, p. 355, doi. 10.1007/s00408-020-00336-3
- By:
- Publication type:
- Article
Eosinophilia Associated With CD3<sup>−</sup>CD4<sup>+</sup> T Cells: Characterization and Outcome of a Single-Center Cohort of 26 Patients.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.01765
- By:
- Publication type:
- Article
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab.
- Published in:
- Respirology Case Reports, 2021, v. 9, n. 2, p. 1, doi. 10.1002/rcr2.707
- By:
- Publication type:
- Article
Eosinophils and eosinophilic immune dysfunction in health and disease.
- Published in:
- European Respiratory Review, 2022, v. 31, n. 163, p. 1, doi. 10.1183/16000617.0150-2021
- By:
- Publication type:
- Article
Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.
- Published in:
- Journal of Leukocyte Biology, 2024, v. 116, n. 2, p. 307, doi. 10.1093/jleuko/qiae051
- By:
- Publication type:
- Article
Revisiting the NIH Taskforce on the Research needs of Eosinophil‐Associated Diseases (RE‐TREAD).
- Published in:
- Journal of Leukocyte Biology, 2018, v. 104, n. 1, p. 69, doi. 10.1002/JLB.5MR0118-028R
- By:
- Publication type:
- Article
Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-112
- By:
- Publication type:
- Article
Eosinophils affect functions of in vitro-activated human CD3-CD4+ T cells.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Case report: Serious unexpected vascular events in two patients with lymphocytic variant hypereosinophilic syndrome.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2023.1256862
- By:
- Publication type:
- Article
Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2662, doi. 10.1111/all.16303
- By:
- Publication type:
- Article
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
- Published in:
- Allergy, 2023, v. 78, n. 1, p. 47, doi. 10.1111/all.15544
- By:
- Publication type:
- Article
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 778, doi. 10.1111/all.15056
- By:
- Publication type:
- Article
Improving Care in Eosinophil-Associated Diseases: A Charter.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2323, doi. 10.1007/s12325-022-02110-8
- By:
- Publication type:
- Article
Oral Corticosteroid Use for the Treatment of Chronic Eosinophilic Disease: A Patient's and His Physician's Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.
- Published in:
- Respiration, 2016, v. 91, n. 5, p. 374, doi. 10.1159/000446076
- By:
- Publication type:
- Article
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases.
- Published in:
- Journal of Patient Experience, 2022, p. 1, doi. 10.1177/23743735221143953
- By:
- Publication type:
- Article
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases.
- Published in:
- Journal of Patient Experience, 2022, v. 9, p. 1, doi. 10.1177/23743735221143953
- By:
- Publication type:
- Article
Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 4, p. 1037, doi. 10.1002/1521-4141(200104)31:4<1037::AID-IMMU1037>3.0.CO;2-#
- By:
- Publication type:
- Article